COMMUNIQUÉS West-GlobeNewswire

Ipsen nominates Catherine Bradley to its Board of Directors as independent Director
29/07/2026
Ipsen appoints Catherine Bradley as independent Director to its Board of Directors PARIS, FRANCE, 29 JULY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today the co-optation of Catherine Bradley, CBE, as an [...]
Ipsen nomme Catherine Bradley en tant que nouvelle administratrice indépendante au sein de son Conseil d’administration
29/07/2026
Ipsen nomme Catherine Bradley, administratrice indépendante au sein de son Conseil d’administration PARIS, FRANCE, 29 JUILLET 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) annonce aujourd'hui la cooptation de Catherine [...]
SOUND Behavioral Health Launches Corporate Community Partner Program During 60th Anniversary Year
29/07/2026
SEATTLE, July 29, 2026 (GLOBE NEWSWIRE) -- As SOUND Behavioral Health celebrates 60 years of serving the Puget Sound region, the organization has launched its new Corporate Community Partner Program, creating meaningful [...]
EssilorLuxottica: Mise à disposition du Rapport financier semestriel 2026
29/07/2026
Mise à disposition du Rapport financier semestriel 2026 Paris, France (29 juillet 2026 – 18h00) – Le Conseil d’administration d’EssilorLuxottica, qui s’est réuni le 28 juillet 2026, a arrêté les comptes consolidés [...]
New Research using Clue Data Suggests Menstrual Cycle Timing May Influence Vaccine Side Effects
29/07/2026
A new study using Clue's menstrual tracking data finds women vaccinated during the follicular phase were more likely to self-report side effects and had a longer time to subsequent infection than those vaccinated during [...]
As New Research Shows Long Covid Affects 1 in 6 Patients, Apheresis Center Analysis Finds US Insurance Policies Are Driving Patients Abroad.
29/07/2026
New research doubles prior US Long Covid estimates, while US patients face insurance denials and a scarcity of domestic apheresis providers offering treatment is driving demand for international H.E.L.P. Apheresis [...]
BPC-157 Introduced by Kylo Peptides for Laboratory Research Purposes
29/07/2026
Sheridan, Wyoming, July 29, 2026 (GLOBE NEWSWIRE) -- Kylo Peptides, a United States research peptide supplier, today announced the addition of BPC-157 to its catalog of research compounds. The synthetic peptide is [...]
The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy
29/07/2026
--Independent Peer Review Provides External Validation of the Trial's Design, Statistical Methodology and Findings-- --Randomized, Double-Blind, Placebo-Controlled HOPE-3 Phase 3 Trial (n=106) Met Primary Endpoint, with [...]
BIOT to Launch Indonesia’s First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia’s Fastest-Growing Aesthetics Markets
29/07/2026
First wave of five directly operated clinics across Indonesia’s five major metropolitan areas with an initial investment of approximately US$1 million; standardized, machine-led clinic format designed for disciplined, [...]
Flyte Partners with LDV at The Maidstone to Elevate Luxury Travel to the Hamptons
29/07/2026
Exclusive Partnership Offers The Maidstone Guests Access and Savings on Flyte's Private Travel Services Collaboration Marks the Beginning of a Long-Term Relationship Connecting Luxury Hospitality with Modern Private [...]
LB Pharmaceuticals Announces $150 Million Private Placement
29/07/2026
NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that [...]
PROLLENIUM® Expands PACE with Launch of Eight New Clinical Education Modules
29/07/2026
New modules, developed with Harley Academy, extend the PACE Training & Education Portal across foundational and advanced clinical techniques RICHMOND HILL, Ontario, July 29, 2026 (GLOBE NEWSWIRE) -- PROLLENIUM® , a [...]
Alvotech announces successful closure of FDA inspection of manufacturing facility
29/07/2026
REYKJAVIK, Iceland, July 29, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for [...]
Walmart Canada, Associates and Customers Raise $7.2 Million to Support Children’s Hospitals Across Canada
29/07/2026
MISSISSAUGA, Ontario, July 29, 2026 (GLOBE NEWSWIRE) -- Walmart Canada, associates and customers came together once again this spring, raising $7.2 million to support children’s hospital foundations across the country. [...]
UroGen Pharma to Report Second Quarter 2026 Financial Results on Wednesday, August 5th, 2026
29/07/2026
Conference Call and Webcast Scheduled for Wednesday, August 5th, 2026, at 10:00 AM ET PRINCETON, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and [...]
MediWound to Report Second Quarter 2026 Financial Results
29/07/2026
MediWound to Report Second Quarter 2026 Financial Results Conference Call and Webcast Scheduled for Thursday, August 13 at 8:30 a.m. Eastern Time YAVNE, Israel, July 29, 2026 -- MediWound Ltd. (Nasdaq: MDWD), a global [...]
Akebia Therapeutics to Report Second Quarter 2026 Financial Results and Discuss Recent Business Highlights
29/07/2026
Akebia to Host Conference Call on August 5 at 4:30 p.m. EDT CAMBRIDGE, Mass., July 29, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA) today announced plans to release its financial results for the [...]
HCW Biologics Inc. Announces Pricing of $1.6 Million Private Placement Offering
29/07/2026
MIRAMAR, Fla., July 29, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”), (NASDAQ: HCWB), a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to [...]
Alvotech announces successful closure of FDA inspection of manufacturing facility
29/07/2026
REYKJAVIK, ICELAND (July 29, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, [...]

Pages